SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Social media platforms are seeing a surge in speculative chatter as investors debate the legitimacy of tokenized pre-IPO assets, with many users warning of potential scams while others track news regarding a long-rumored SpaceX public offering. Community members are actively analyzing the aerospace sector, focusing on the potential impact of a high-profile IPO and debating whether current market excitement reflects genuine valuation or a bubble driven by retail FOMO.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is attracting significant attention as investors speculate on its role in the AI-agent infrastructure space, with the community actively discussing potential institutional interest and long-term utility. Despite recent price volatility, supporters are highlighting bullish ecosystem developments and active development as reasons to maintain a long-term position.

Swell

The community is actively debating the potential of Swell, with supporters highlighting its liquid staking utility, institutional backing, and low market cap as key drivers for long-term growth. Conversely, critics frequently dismiss the asset as a speculative project, pointing to recurring price volatility and concerns over supply issuance as reasons for caution.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. (EMAT) is gaining momentum as investors weigh its potential as a vertically integrated domestic rare earth magnet manufacturer against concerns regarding its micro-float and high insider ownership. Community discussion is split between excitement over the stock's positioning as a strategic alternative to foreign supply chains and caution regarding its characteristic high volatility and potential for sharp price swings.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

League of Degens 

The community is actively discussing $DEGEN, pointing to a mix of optimism surrounding potential exchange listings and a new beta app while others express frustration over token performance. Investors remain hyper-focused on upcoming project catalysts and social media branding as they debate whether the token is currently at a critical accumulation phase.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following an exclusive U.S. supply agreement for the Tokyo strain of BCG to address the ongoing domestic shortage, a move the community views as a strategic breakthrough that strengthens the company's competitive position against major pharmaceutical players. Investors are actively discussing the potential for accelerated regulatory pathways, the synergy between this supply and Anktiva, and the anticipation of further catalysts being revealed at the upcoming American Urological Association conference.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors monitor Q4 earnings results and weigh the ongoing growth of immunology blockbusters Skyrizi and Rinvoq against the managed decline of Humira revenues. Meanwhile, community discussions are heavily focused on the company's potential M&A appetite in the obesity and oncology sectors, with retail sentiment remaining vigilant regarding potential competitive threats and pipeline expansion strategies.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: United States, Germany, and Other. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

WW International Inc - Ordinary Shares - New

WW International, Inc. Common Stock

WW International is gaining traction as investors speculate on a turnaround driven by strategic partnerships with GLP-1 medication providers and debt-reduction efforts. The community remains divided, with some betting on a successful pivot toward clinical weight-loss solutions while others remain skeptical due to the company's historical financial struggles and competitive pressure.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is experiencing a surge in investor interest driven by strong prescription growth, successful patent protection, and a clear path toward operating profitability in the coming quarters. The community is actively discussing the stock's potential for acquisition by larger pharmaceutical firms, while closely monitoring the ongoing battle against high short interest and institutional accumulation patterns.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render Token is currently capturing significant attention as investors double down on decentralized AI infrastructure and GPU-based compute plays. The community is heavily focused on the protocol's utility in the expanding AI landscape, with many traders actively accumulating positions while discussing its long-term potential compared to other artificial intelligence and DePIN projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>North America and U.S. comparable sales rose 4%, driven by a 3% increase in transactions and a 1% lift in average spending per visit.</li><li>For fiscal 2026, the company expects global and U.S. comparable store sales growth of at least 3%, with net revenue rising at a similar pace.</li><li>Starbucks plans to open about 600 to 650 net new stores worldwide in fiscal 2026.</li></ul>Starbucks shares rose more than 7% in premarket trading on Wednesday after the coffee giant delivered U.S. comparable transaction growth for the first time in eight quarters.North America and the U.S. comparable sales rose 4%, driven by a 3% increase in transactions and a 1% lift in average spending per visit.“What we’re really delighted about is that the North American comp result is driven by transactions and specifically the fact that both non-rewards customers and rewards customers grew transactions. So, two things happened: people came back to the brand, and we also drove engagement with our existing customers,” Brian Niccol, chairman and CEO, said in a call with analysts.<h2 class="st-heading-2">FY2026 Outlook</h2>For fiscal 2026, the company expects global and U.S. comparable store sales growth of at least 3%, with net revenue rising at a similar pace.It also forecast a slight year-over-year improvement in non-GAAP operating margin and earnings per share of $2.15 to $2.40. Starbucks plans to open about 600 to 650 net new stores worldwide.<h2 class="st-heading-2">Q1 Revenue Beats Estimates</h2>Starbucks posted a 5.5% increase in first-quarter (Q1) revenue to $9.92 billion, which also came above Wall Street estimates of $9.65 billion, according to Fiscal.ai data. However, earnings of $0.26 per share were significantly below Street estimates of $0.59 per share.The company said operating margin fell to 9% due to higher labor spending tied to the “Back to Starbucks” strategy and inflation pressures from elevated coffee prices and tariffs. Starbucks earmarked $500 million for the “Back to Starbucks” strategy to improve staffing, service, and operations.“Our Q1 results demonstrate our ‘Back to Starbucks’ strategy is working, and we believe we’re ahead of schedule,” Niccol added, pointing to renewed sales momentum.International comparable sales grew 5%, led by higher traffic and ticket sizes, while China posted a stronger 7% increase driven by a 5% jump in transactions. Net revenue from China rose 11% to $823.4 million as store count increased 4% to 8,011 locations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes. <a href="https://stocktwits.com/symbol/SBUX">SBUX</a> was among the top trending tickers on the platform at the time of writing.<img src="https://news.stocktwits-cdn.com/SBUX_jpg_77a36f8141.webp" alt="SBUX.jpg">One user sounded bullish about the sector.<stembedurl>https://stocktwits.com/CDML115/message/643116424</stembedurl>Another user expects the stock to climb to $120.It is currently trading around $103.<stembedurl>https://stocktwits.com/Srinivas111/message/643117843</stembedurl>Over the past year, the stock has declined by around 3%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-bio-key-bkyi-stock-is-up-today-cybersecurity-deal/cmygd2dR40c">This Nano Cap&nbsp;Cybersecurity&nbsp;Stock Surged Over 70% In Pre-Market Today – What Is The Portugal Connection?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Starbucks app page is displayed on a smartphone in front of the Starbucks corporate logoStarbucks has appointed Amazon tech leader Anand Varadarajan as its CTO. (Photo by Cheng Xin/Getty Images)

SBUX Stock Jumps 7% Today – US Transactions Grow For The First Time In Two Years

Starbucks posted a 5.5% increase in first-quarter revenue to $9.92 billion, which also came above Wall Street estimates of $9.65 billion, according to Fiscal.ai data.

AVRY
EA Series Trust - Avory Foundational ETF

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest AVRY News

AVRYEA Series Trust - Avory Foundational ETF